A detailed history of Pom Investment Strategies, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Pom Investment Strategies, LLC holds 24 shares of PRTA stock, worth $363. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 24 -0.0%
Holding current value
$363
Previous $495,000 18.79%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$24.75 - $40.66 $594 - $975
24 New
24 $594,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $710M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Pom Investment Strategies, LLC Portfolio

Follow Pom Investment Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pom Investment Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pom Investment Strategies, LLC with notifications on news.